NADPH oxidase is not required for spontaneous and Staphylococcus aureus-induced apoptosis of monocytes

Annals of Hematology

Volumn 83, Issue 4, 2004, Pages 206-211

  Bernuth, Horst V ^a   Kulka, C ^a   Roesler, J ^a   Gahr, M ^a   Rosen Wolff A ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

Apoptosis; Chronic granulomatous disease; Monocytes; NADPH oxidase; Reactive oxygen intermediates

Indexed keywords

FAS ANTIGEN; FAS LIGAND; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CELL MANIPULATION; CHRONIC GRANULOMATOUS DISEASE; CONTROLLED STUDY; DATA ANALYSIS; EXPERIMENTATION; HUMAN; HUMAN CELL; MOLECULAR MODEL; MONOCYTE; NONHUMAN; PHAGOCYTE; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN FUNCTION; STAPHYLOCOCCUS AUREUS;

ANTIGENS, CD95; APOPTOSIS; FAS LIGAND PROTEIN; GRANULOMATOUS DISEASE, CHRONIC; HUMANS; HYDROGEN PEROXIDE; MEMBRANE GLYCOPROTEINS; MONOCYTES; NADPH OXIDASE; PHAGOCYTOSIS; REACTIVE OXYGEN SPECIES; STAPHYLOCOCCUS AUREUS;

EID: 1842582046     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-003-0837-4     Document Type: Article

References (28)

1. Babior BM (1999) NADPH oxidase: An update. Blood 93:1464-1476
2. Bantel H, Sinha B, Domschke W, Peters G, Schulze-Osthoff K, Janicke RU (2001) Alpha-toxin is a mediator of Staphylococcus aureus-induced cell death and activates caspases via the intrinsic death pathway independently of death receptor signaling. J Cell Biol 155:637-648
3. Baran J, Weglarczyk K, Mysiak M, Guzik K, Ernst M, Flad HD, Pryjma J (2001) Fas (CD95)-Fas ligand interactions are responsible for monocyte apoptosis occurring as a result of phagocytosis and killing of Staphylococcus aureus. Infect Immun 69:1287-1297
4. Bauer MK, Vogt M, Los M, Siegel J, Wesselborg S, Schulze-Osthoff K (1998) Role of reactive oxygen intermediates in activation-induced CD95 (APO-1/Fas) ligand expression. J Biol Chem 273:8048-8055
5. Cale CM, Jones AM, Goldblatt D (2000) Follow up of patients with chronic granulomatous disease diagnosed since 1990. Clin Exp Immunol 120:351-355
6. Emmendorffer A, Nakamura M, Rothe G, Spiekermann K, Lohmann-Matthes ML, Roesler J (1994) Evaluation of flow cytometric methods for diagnosis of chronic granulomatous disease variants under routine laboratory conditions. Cytometry 18:147-155
7. Gardai S, Whitlock BB, Helgason C, Ambruso D, Fadok V, Bratton D, Henson PM (2002) Activation of SHIP by NADPH oxidase-stimulated Lyn leads to enhanced apoptosis in neutrophils. J Biol Chem 277:5236-5246
8. Grage-Griebenow E, Flad HD, Ernst M (2001) Heterogeneity of human peripheral blood monocyte subsets. J Leukoc Biol 69:11-20
9. Hampton MB, Orrenius S (1997) Dual regulation of caspase activity by hydrogen peroxide: Implications for apoptosis. FEBS Lett 414:552-556
10. Hiraoka W, Vazquez N, Nieves-Neira W, Chanock SJ, Pommier Y (1998) Role of oxygen radicals generated by NADPH oxidase in apoptosis induced in human leukemia cells. J Clin Invest 102:1961-1968
11. Hyslop PA, Hinshaw DB, Scraufstatter IU, Cochrane CG, Kunz S, Vosbeck K (1995) Hydrogen peroxide as a potent bacteriostatic antibiotic: implications for host defense. Free Radic Biol Med 19:31-37
12. Kasahara Y, Iwai K, Yachie A, Ohta K, Konno A, Seki H, Miyawaki T, Taniguchi N (1997) Involvement of reactive oxygen intermediates in spontaneous and CD95 (Fas/APO-1)-mediated apoptosis of neutrophils. Blood 89:1748-1753
13. Kerr JF, Wyllie AH, Currie AR (1972) Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26:239-257
14. Krammer PH (2000) CD95's deadly mission in the immune system. Nature 407:789-795
15. Leusen JH, de Klein A, Hilarius PM, Ahlin A, Palmblad J, Smith CI, Diekmann D, Hall A, Verhoeven AJ, Roos D (1996) Disturbed interaction of p21-rac with mutated p67-phox causes chronic granulomatous disease. J Exp Med 184:1243-1249
16. Liese J, Kloos S, Jendrossek V, Petropoulou T, Wintergerst U, Notheis G, Gahr M, Belohradsky BH (2000) Long-term follow-up and outcome of 39 patients with chronic granulomatous disease. J Pediatr 137:687-693
17. Los M, Wesselborg S, Schulze-Osthoff K (1999) The role of caspases in development, immunity, and apoptotic signal transduction: lessons from knockout mice. Immunity 10:629-639
18. Moulton P, Martin H, Ainger A, Cross A, Hoare C, Doel J, Harrison R, Eisenthal R, Hancock J (2000) The inhibition of flavoproteins by phenoxaiodonium, a new iodonium analogue. Eur J Pharmacol 401:115-120
19. Ritter M, Buechler C, Langmann T, Orso E, Klucken J, Schmitz G (1999) The scavenger receptor CD163: Regulation, promoter structure and genomic organization. Pathobiology 67:257-261
20. Robertson AK, Cross AR, Jones OT, Andrew PW (1990) The use of diphenylene iodonium, an inhibitor of NADPH oxidase, to investigate the antimicrobial action of human monocyte derived macrophages. J Immunol Methods 133:175-179
21. Roesler J, Heyden S, Burdelski M, Schafer H, Kreth HW, Lehmann R, Paul D, Marzahn J, Gahr M, Rosen-Wolff A (1999) Uncommon missense and splice mutations and resulting biochemical phenotypes in German patients with X-linked chronic granulomatous disease. Exp Hematol 27:505-511
22. Roos D (1996) X-CGDbase: A database of X-CGD-causing mutations. Immunol Today 17:517-521
23. Seger RA, Ezekowitz RA (1994) Treatment of chronic granulomatous disease. Immunodeficiency 5:113-130
24. Suzuki Y, Ono Y, Hirabayashi Y (1998) Rapid and specific reactive oxygen species generation via NADPH oxidase activation during Fas-mediated apoptosis. FEBS Lett 425:209-212
25. Um HD, Orenstein JM, Wahl SM (1996) Fas mediates apoptosis in human monocytes by a reactive oxygen intermediate dependent pathway. J Immunol 156:3469-3477
26. van Engeland M, Nieland LJ, Ramaekers FC, Schutte B, Reutelingsperger CP (1998) Annexin V-affinity assay: A review on an apoptosis detection system based on phosphatidylserine exposure. Cytometry 31:1-9
27. Williams MA, Withington S, Newland AC, Kelsey SM (1998) Monocyte anergy in septic shock is associated with a predilection to apoptosis and is reversed by granulocyte-macrophage colony-stimulating factor ex vivo. J Infect Dis 178:1421-1433
28. Winkelstein JA, Marino MC, Johnston RB, Jr., Boyle J, Curnutte J, Gallin JI, Malech HL, Holland SM, Ochs H, Quie P, Buckley RH, Foster CB, Chanock SJ, Dickler H (2000) Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore) 79:155-169